Compugen | CGEN - Ebit


Compugen reported $-8.84M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Arca Biopharma USD -36.43M 2M Mar/2026
aTyr Pharma USD -94.72K 26.75K Jun/2026
Bio Path USD -297K 191K Mar/2026
Brainstorm Cell Therapeutics USD -2.05M 1000 Mar/2026
Cara Therapeutics USD -7.05M 1.11M Mar/2026
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD -8.84M 180K Jun/2026
Immunic USD -23.33M 2.67M Dec/2025
Minerva Neurosciences USD -4.37M 1.71M Sep/2024
RedHill Biopharma USD 2.69M 47.97M Jun/2023
TherapeuticsMD USD -1.77M 699K Sep/2023